Showing 471-480 of 19185 results for "".
Home Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year
https://reachmd.com/programs/the-jama-report/home-monitoring-blood-sugar-did-not-improve-glycemic-control-after-1-year/9653/A study in JAMA suggests that self-monitoring should not be routine in patients with type 2 diabetes who are not treated with insulinUnfair Treatment of Phase I Clinical Trial Subjects
https://reachmd.com/programs/clinicians-roundtable/unfair-treatment-of-phase-i-clinical-trial-subjects/3395/Dr. Jonathan Kimmelman, assistant professor of the Biomedical Research unit at McGill University, discusses with host Dr. Maurice Pickard what appears to be a ‘job' that may exploit the underclass in Phase 1 clinical studies. The poor in the studies are less likely to have access to the drugs when aKey Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
https://reachmd.com/programs/diabetes-discourse/key-insights-from-grade-exploring-data-on-glycemia-reduction-in-t2d/14619/What did we learn about treatment options for patients with type 2 diabetes from the GRADE study?Diabetes Research Suggests Better Long Term Outcomes with Early Insulin
https://reachmd.com/programs/everyday-family-medicine/diabetes-research-suggests-better-long-term-outcomes-with-early-insulin/7754/Host Jennifer Caudel, DO welcomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association's annual medical education conference, Dr. Shubrook discusses a pilot studSotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
https://reachmd.com/clinical-practice/cardiology/sotagliflozin-in-hfpef-without-diabetes-inside-the-sota-p-cardia-trial-from-aha-2025/39898/SOTA-P-CARDIA shows sotagliflozin improves LV mass, exercise capacity, and quality of life in non-diabetic HFpEF, supporting dual SGLT1/2 inhibition.Optimizing Outcomes in Diabetic Limb Preservation
https://reachmd.com/programs/clinicians-roundtable/optimizing-outcomes-in-diabetic-limb-preservation/36427/Effective diabetic limb preservation is not only about preserving length. It's equally important to focus on functional outcomes, taking a patient-centered approach that considers key factors like mobility, age, dialysis status, and blood flow. Join Dr. Paul Kim as he discusses these decision-makingHow Overnight Glucose Levels Impact Daily Activities in T1D Patients
https://reachmd.com/programs/diabetes-discourse/how-overnight-glucose-levels-impact-daily-activities-in-t1d-patients/16255/Dive into the findings from a recent study that explored the impacts of overnight glucose levels on patients with type 1 diabetes.Part 2: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease
https://reachmd.com/programs/heart-matters/part-2-a-plant-based-diet-for-preventing-and-possibly-reversing-coronary-artery-disease/6332/Some evidence suggests it is possible to prevent and reverse heart disease by adhering to a plant-based diet, but lifestyle changes are often the most challenging for physicians to prescribe and for patients to adopt. What strategies can physicians use to encourage a plant-based diet for patients whHot Topic: Can Global Warming Affect Diabetes Rates?
https://reachmd.com/programs/what-your-patients-are-talking-about/hot-topic-can-global-warming-affect-diabetes-rates/9593/Dr. Brian McDonough looks into a possible correlation between global warming and diabetes.Over-The-Counter Options for Diabetics
https://reachmd.com/programs/clinicians-roundtable/over-the-counter-options-for-diabetics/3756/Diabetes has become such a worldwide epidemic that some are turning to over-the-counter products as a way to help patients with this disease that has afflicted nearly 24 million in the U.S. alone. Dr. Gerald Bernstein, the vice president of medical affairs at Generex, a biotech company based in Toro